ALKBH5 reverses romidepsin-mediated anti-multiple myeloma activity via regulation of m6A modification of FOXM1
- 24 May 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 239, 116998
Abstract
No abstract availableKeywords
Funding Information
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital (GSPJS202420, GSPJS202414, GSPJS202417)
- Qinglan Project of Jiangsu Province of China
- Natural Science Research of Jiangsu Higher Education Institutions of China (22KJA320011)
- Xuzhou Science and Technology Program (KC22071)
This publication has 37 references indexed in Scilit:
- Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal CancerAdvanced Science, 2025
- Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5Leukemia Research, 2024
- HDAC-targeting epigenetic modulators for cancer immunotherapyEuropean Journal of Medicinal Chemistry, 2024
- Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m 6 A RNA methylation in ocular melanomaCancer Communications, 2023
- N6‐methyladenosine (m6A) modification in gynecological malignanciesJournal of Cellular Physiology, 2022
- The role of m6A RNA methylation in cancerBiomedicine & Pharmacotherapy, 2019
- m 6 A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation ProgramCancer Cell, 2017
- Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphomaCancer Letters, 2015
- Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cellsBiomedicine & Pharmacotherapy, 2014
- Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myelomaCancer, 2010